1. 1Pediatric Oncology Branch and
2. 2Biostatistics and Data Management Section, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD;
3. 3Division of Hematology/Oncology, Department of Pediatrics, University of Florida, Gainesville, FL;
4. 4Center for Cancer and Blood Disorders, Children’s National Hospital, Washington, DC;
5. 5Université Montpellier, Institut de Génétique Moléculaire de Montpellier, CNRS, Montpellier, France;
6. 6Laboratory of Integrative Cancer Immunology, CCR, NCI, NIH, Bethesda, MD;
7. 7Lentigen, a Miltenyi Biotec Company, Gaithersburg, MD;
8. 8Department of Pediatrics, City of Hope, Duarte, CA;
9. 9Center for Cellular Engineering, Department of Transfusion Medicine, NIH Clinical Center, Bethesda, MD;
10. 10Department of Hematology, Seattle Cancer Care Alliance, University of Washington, Seattle, WA;
11. 11Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA;
12. 12Department of Pediatrics and
13. 13Department of Medicine, Stanford University, Stanford, CA;
14. 14Department of Pediatric Hematology/Oncology, Department of Pediatrics, University of Virginia, Charlottesville, VA;
15. 15University of Virginia Cancer Center, Charlottesville, VA;
16. 16Radiology and Imaging Sciences, NIH Clinical Center, Bethesda, MD;
17. 17Laboratory of Pathology, CCR, NCI, NIH, Bethesda, MD;
18. 18Applied Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD;
19. 19Clinical Research Directorate, Frederick National Laboratory for Cancer Research, NCI, Frederick MD; and
20. 20University of Colorado Anschutz Medical Campus and Center for Cancer and Blood Disorders, Children’s Hospital of Colorado, Aurora, CO